Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公司

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Bu, Su 卜素 NED 88 88
2 Chan, Peter Kin Sang 陳健生 INED 23 23
3 Cheng, Gary Faat Ting 鄭發丁 INED 93 93
4 Chow, Ching Man (1985) 周靖文 INED 93 93
5 Chow, Joseph Kwok Fai 周國輝 INED 93 93
6 He, Jiaming (1985) 何嘉明 ED 445 37 17 499
7 Poon, Michael Lai Yin 潘禮賢 FD 597 37 32 666
8 Shih, Mei Ling 施美伶 INED 7 7
9 Xu, Ming (1959) 徐明 NED 21 21
10 Zhang, Chunguang (1968) 張春光 CEO 312 300 97 709
11 Zhang, Shuguang (1970) 張曙光 Ch 264 136 82 482
Total 418 1,618 510 228 0 2,774

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 418 1,618 510 228 0 2,774 Report
2023-12-31 308 1,708 516 211 0 2,743 Report
2022-12-31 258 2,065 668 0 0 2,991 Report
2021-12-31 249 2,053 151 0 0 2,453 Report
2020-12-31 268 1,801 139 0 1,636 3,844 Report
2019-12-31 264 787 181 0 0 1,232 Report
2018-12-31 12 440 39 58 0 549 Report
Total 1,777 10,472 2,204 497 1,636 16,586

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top